#65 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians treating young patients with stroke should screen for recreational drug use, particularly cannabis and cocaine, as these substances significantly elevate stroke risk in this population and may inform acute management decisions. Understanding cannabis-associated stroke mechanisms allows providers to counsel patients on modifiable risk factors and identify those requiring closer cardiovascular monitoring. This evidence supports including substance use history as a standard component of stroke risk assessment in younger demographics where traditional risk factors may be absent.
A recent epidemiological analysis found that recreational drug use, including cannabis, is associated with a threefold increased risk of stroke in young people, with specific drugs showing distinct vascular complications. The study identified that cocaine use disorder was particularly linked to brain hemorrhage and cardioembolic stroke, while cannabis use contributed to overall stroke risk in this population. These findings suggest that drug-related vasculopathy and thrombotic mechanisms represent an underrecognized cardiovascular hazard in younger patients presenting with acute neurological symptoms. Clinicians should maintain a high index of suspicion for stroke in young patients with recreational drug use histories and may need to screen for cannabis and other substance use as part of cardiovascular risk assessment in this demographic. For patients using cannabis, particularly those with additional cardiovascular risk factors, physicians should counsel on the potential association between use and acute stroke risk as part of comprehensive harm reduction counseling.
“We need to distinguish between occasional cannabis use and the heavy, frequent consumption patterns that actually elevate stroke risk in younger patients, because the clinical reality is more nuanced than headlines suggest, but the vascular risk is real enough that I counsel patients with migraine, hypertension, or cardiac history to avoid it entirely.”
🧠 While this study identifies concerning associations between recreational drug use and stroke risk in young adults, clinicians should recognize that observational data cannot establish causation and that unmeasured confounders—such as smoking, hypertension, or concurrent use of multiple substances—may partially explain these associations. The specific mechanisms linking cannabis to stroke remain incompletely understood, and reported effect sizes vary substantially across studies depending on frequency of use, route of administration, and individual cardiovascular risk profiles. When taking histories from younger stroke patients, providers should routinely ask about cannabis and other drug use without assuming causation, while remaining alert to the possibility that some patients may benefit from substance use counseling or cardiology referral for further risk stratification. Given the growing prevalence of cannabis use in this population and its legal status in many jurisdictions, clinicians should incorporate discussion of potential cerebrovascular risks into shared decision-making conversations with young adults, particularly those with additional stroke risk
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: